Pain in patients with lung cancer: Pathophysiology and treatment

Lung Cancer

Volumn 68, Issue 1, 2010, Pages 10-15

  Mercadante, Sebastiano ^a   Vitrano, Valentina ^a  

^a LA MADDALENA CANCER CENTER   (Italy)

Author keywords

Breakthrough pain; Cancer pain; Lung cancer; Opioid switching; Opioids; Pain syndromes; Palliative care

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPRENORPHINE; CISPLATIN; CORTICOSTEROID; FENTANYL; HYDROMORPHONE; KETAMINE; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PACLITAXEL; TRICYCLIC ANTIDEPRESSANT AGENT; VINCA ALKALOID;

ACCOMMODATION; ANALGESIA; BONE METASTASIS; BONE PAIN; CANCER PAIN; CANCER RADIOTHERAPY; CONSTIPATION; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERABILITY; DRUG TRANSFORMATION; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MALIGNANT BRACHIAL PLEXOPATHY; NAUSEA; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; THORAX PAIN; TUMOR LOCALIZATION; URINE RETENTION; VISCERAL PAIN; VOMITING; XEROSTOMIA;

ANALGESICS, OPIOID; ANIMALS; DRUG THERAPY; HUMANS; LUNG NEOPLASMS; PAIN; PAIN, POSTOPERATIVE; PALLIATIVE CARE; RADIOTHERAPY;

EID: 77649192570     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.11.004     Document Type: Review

References (35)

1. Schofield P., Ugalde A., Carey M., Mileshkin L., Duffy M., Ball D., et al. Lung cancer: challenges and solutions for supportive care intervention research. Pall Support Care 6 (2008) 281-287
2. Potter J., and Higginson I.J. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology. Lung Cancer 43 (2004) 247-257
3. Barbera L., Paszat L., and Qiu F. End-of-life care in lung cancer patients in Ontario: aggressiveness of care in the population and a description of hospital admissions. J Pain Symptom Manage 35 (2008) 267-274
4. Mercadante S., Armata M., and Salvaggio L. Pain characteristics of advanced lung cancer patients referred to a palliative care service. Pain 59 (1994) 141-145
5. Wildgaard K., Ravn J., and Kehlet H. Chronic post-thoractomy pain: a critical review of pathogenic mechanisms and strategies for prevention. Eur J Cardiol Thorac Surg 36 (2009) 170-180
6. Jaeckle K.A. Neurological manifestations of neoplastic and radiation-induced plexopaties. Semin Neurol 24 (2004) 385-393
7. Portenoy R.K., Miransky J., Thaler H., Hornung J., Bianchi C., Cibas-Kong I., et al. Pain in ambulatory patients with lung or colon cancer. Cancer 70 (1992) 1616-1624
8. Wilkie D., Hsiu-Ying H., Reilly N., and Cain K.A. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage 22 (2001) 899-910
9. Grond S., Zech D., Diefenbach C., Radbruch L., and lehmann K.A. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 64 (1996) 107-114
10. Mercadante S. Malignant bone pain: physiopathology, assessment and treatment. Pain 69 (1997) 1-18
11. Mercadante S. Neoplasm-induced pain. In: Gilman S. (Ed). Neurobiology of disease (2007), Elsevier, San Diego 1007-1020
12. Portenoy R.K., and Conn M. Cancer pain syndromes. In: Bruera E., and Portenoy R.K. (Eds). Cancer pain, assessment and management (2003), Cambridge University Press 38-50
13. Chi D., Behin A., and Delattre J.Y. Neurologic complications of radiation therapy. In: Schiff D., Kesari S., and Wen P.Y. (Eds). Current Clinical oncology: cancer neurology in clinical practice (2008), Humana Press 259-286
14. Kori S.H., Foley K.M., and Posner J.B. Brachial plexus lesions in patients with cancer: 100 cases. Neurology 31 (1981) 45-50
15. Balduyck B., Hendriks J., Lauwers P., and Van Schil P. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients. Lung Cancer 56 (2007) 423-431
16. Balduyck B., Hendriks J., Lauwers P., and Van Schil P. Quality of life after lung cancer surgery: a prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy. J Thorac Oncol 3 (2008) 604-608
17. Balduyck B., Hendriks J., Lauwers P., and Van Schil P. Quality of life evolution after lung cancer surgery in septuagenarians: a prospective study. Eur J Cardiol Thorac Surg 35 (2009) 1070-1075
18. Hanks G.W., and Expert Working Group of the Research Network of the EAPC. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84 (2001) 587-593
19. Jadad A.R., and Browman G.P. The WHO analgesic ladder for cancer pain management. JAMA 274 (1995) 1870-1873
20. Mercadante S., Porzio G., Ferrera P., Fulfaro F., Aielli F., Ficorella C., et al. Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage 31 (2006) 242-247
21. Portenoy R.K., and Hagen N.A. Breakthrough pain: definition, prevalence, and characteristics. Pain 41 (1990) 273-281
22. Cherny N.J., Chang V., Frager G., Ingham J.M., Tiseo P.J., Popp B., et al. Opioid pharmacotherapy in the management of cancer pain. Cancer 76 (1995) 1288-1293
23. Mercadante S. Cancer pain. In: Schiff D., Kesari S., and Wen P.Y. (Eds). Cancer neurology in clinical practice (2008), Humana Press 113-128
24. Clemens K.E., and Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage 33 April (4) (2007) 473-481
25. Davies A.N., Dickman A., Reid C., Stevens A.M., and Zeppetella G. Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 13 (2009) 331-338
26. Mercadante S., and Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94 (2002) 832-839
27. Mercadante S., and Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev 32 (2006) 304-315
28. Bolan E., Tallarida R., and Pasternak G. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther 303 (2002) 557-562
29. Mercadante S., Villari P., Ferrera P., and Casuccio A. Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer 12 (2004) 762-766
30. Portenoy R.K., and Rowe G. Adjuvant analgesic drugs. In: Bruera E., and Portenoy R.K. (Eds). Cancer pain, assessment and management (2003), Cambridge University Press 188-198
31. Mercadante S., Arcuri E., Tirelli W., Villari P., and Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori 88 (2002) 239-242
32. Caraceni A., Zecca E., Bonezzi C., Arcuri E., Yaya Tur R., Maltoni M., et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22 (2004) 2909-2917
33. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 79 (1999) 1-13
34. Mercadante S., Intravaia G., Villari P., Ferrera P., Riina S., David F., et al. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain 23 (2007) 793-798
35. Tasker R.R. Neurosurgical and neuroaugmentative intervention. In: Patt R.B. (Ed). Cancer pain (1993), JB Lippincott Co., Philadelphia 471-500